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The editors of Contemporary Issues in Women’s
Health solicit reporters and correspondents from
throughout the world to make contributions to
this section. Please feel free to e-mail or other-
wise contact Dr. Timothy Johnson at
or Prof. S. Arulkumaran attrbj@umich.edu
if you have reports ors.arulkumaran@sghms.ac.uk
stories that you would like to have included. We
would be happy to attribute the items to those
reporters and correspondents who give permission
in their transmittal. Otherwise, we will share those
reports that we think are of the greatest interest to
our readership without attribution.
1. FDA Public Health Notification: PVC devices
containing the plasticizer DEHP
Polyvinyl chloride (PVC) is a plastic polymer
that is used in a wide array of products. Non-plas-
ticized PVC is hard and brittle at room tempera-
ture. A plasticizer (softener) is typically added to
increase the flexibility of the polymer. Di-(2-ethyl-
hexyl)phthalate (DEHP) is the plasticizer used in
most PVC products. Devices that may contain
DEHP include intravenous bags and tubing, umbil-
ical artery catheters, blood bags and infusion tub-
ings, nasogastric tubes and peritoneal dialysis bags
and tubing. DEHP can leach out of plastic medical




devices into solutions that come into contact with
the plastic. The amount of DEHP that will leach
out depends on the temperature, the lipid content
of the liquid, and the duration of contact with the
plastic. Seriously ill individuals often require more
than one of these procedures, thus exposing them
to even higher levels of DEHP. In young animals,
prolonged exposure affects development of the
male reproductive system and the production of
normal sperm. There are no reported adverse
events in humans. Although the chances of such
problems are unlikely, it is better to avoid pro-
longed exposure of the developing male to DEHP.
The procedures that may pose risks of exposure are
exchange transfusions in neonates, ecmo in neo-
nates, total parenteral nutrition in neonates, multi-
ple procedures in sick neonates, hemodialysis in
pregnant or lactating women and massive transfu-
sion of blood. There is little or no risk posed by
patient exposure to the amount of DEHP released
from PVC intravenous bags during the infusion of
crystalloid fluids, e.g. normal saline or Ringers lac-
tate. The PVC bags used to store and administer
drugs that require a pharmaceutical vehicle for
solubilization, when label instructions are fol-
lowed, do not pose a threat.
One has to weigh the risks of using such plas-
ticized bags or tubings with DEHP, against the risk
of not doing a needed procedure, as that may be
greater. For prolonged use of PVC devices, mate-
rials that do not contain DEHP can be substituted.
This comes in the form of silicone or poly-
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ethylene or polyurethane. More information on
this subject can be obtained from
. An addition-http:yywww.sustainablehospitals.org
al website to visit is
.www.fda.govycdrhyostydehp-pvc.pdf
2. Progesterone and preterm birth
The mechanism of initiation of preterm labor
could be multifactorial. Infections, cervical incom-
petence and multiple pregnancies may contribute
to a proportion of cases, but the vast majority are
due to unknown causes. Csapo w1x postulated that
the reversal of high progesterone to estrogen ratio
leads to uterine activity and labor. Administration
of progesterone to prevent or postpone preterm
labor has shown promise in the past w2x and recent
trials w3,4x have brought renewed hope. Use of
vaginal progesterone suppositories (100 mg) daily
has been shown to be of value to reduce the num-
ber of babies being born prior to 34 weeks, as well
as 37 weeks. Such treatment has few side effects
and is affordable and is likely to be acceptable to
women, who face the threat of preterm labor of
unknown etiology.
References
w1x Csapo AI. The see-saw theory of parturition. In:
O’Connor M, Knight J. editors. The fetus and birth.
New York: Elsevier, 1977, pp. 159–210.
w2x Keirse MJNC. Progesterone administration in preg-
nancy may prevent pre-term delivery. Br J Obstet
Gynecol 1990: 97: 149–154.
w3x da Fonseca EB, Bittar RE, Carvalho MHB, Zugaib M.
Prophylactic administration of progesterone by vaginal
suppositories to reduce the incidence of spontaneous
preterm birth in women at increased risk: a random-
ized placebo-controlled double-blind study. Am J
Obstet Gynecol 2003:188:419–424.
w4x Meis PJ, National Institute of Child Health and Human
Development Maternal Fetal Medicine Units Network.
17a-Hydroxyprogesterone acetate to prevent recurrent
preterm birth (abstract). Am J Obstet Gynecol
2002;187:554.
3. Meconium aspiration
Oral pharyngeal followed by naso-pharyngeal
suction before delivery of the shoulder has been
recommended to prevent meconium aspiration
(American College of Pediatrics and American
College of Obstetricians and Gynecologists). Stud-
ies have shown that this practice has not reduced
the incidence of meconium aspiration. This indi-
cates that in many cases the aspiration has hap-
pened prior to delivery. There is emerging evidence
to suggest that reduction of oxygen saturation and
hypocarbia in the fetus may cause gasping move-
ments and meconium aspiration even before there
is any change in the pH. Although such recent
observation explains the possible mechanism, the
point of time such an event is likely to happen in
labor will be unpredictable and hence pulse oxi-
metry may not be of value to predict or prevent
meconium aspiration. Meta-analysis of trials done
on amnioinfusion for meconium-stained liquor
suggests possible reduction of meconium aspira-
tion syndrome w1,2x. Additional information can be
obtained from the website http:yywww.obgyn.net.
Title: Suctioning Doesn’t Alter Meconium Aspira-
tion Risk by Sherry Boschert.
References
w1x Hofmeyr GJ, Gulmezoglu AM, Buchmann E et al. The
collaborative randomised amnio-infusion for mecon-
ium project (CRAMP): 1. South Africa. Br J Obstet
Gynaecol 1998;105:304–308.
w2x Mahomed K, Mulambo T, Woelk G, Hofmeyr GJ, Gul-
mezoglu AM. Collaborative randomised amnio-infu-
sion for meconium project (CRAMP): 2. Zimbabwe.
Br J Obstet Gynaecol 1998:309–313.
4. Assessment of guidelines for good practice in
psychosocial care of mothers after stillbirth: a
cohort study
There is a strong belief that mothers should be
encouraged to see and hold their dead infant after
a stillbirth. This practice is encouraged with the
hope that the mother will have less psychological
morbidity in the future. There is, however, no evi-
dence to support this view. The above study by
Hughes et al. published in The Lancet w1x indicates
that the promotion of contact with the stillborn
infant led to more depression, anxiety and post-
traumatic stress disorder in the subsequent preg-
nancy and 1 year after the next birth. There was
also disorganized attachment behavior to the new-
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born infant. This study included only 65 women
after stillbirth and 60 control women. This is an
important finding and a larger study is warranted
in order to evaluate whether the practice of encour-
aging mothers to hold the stillborn infant and keep-
ing mementos will adversely affect their
psychological health in subsequent pregnancies.
Until such studies are performed, practice should
be tailored to individual mothers or couples’
requests.
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5. Cesarean delivery does not prevent anal
incontinence
A recent paper w1x studied the incidence of anal
incontinence after cesarean delivery and vaginal
delivery. The study used a comprehensive ques-
tionnaire, which was sent to mothers who delivered
by cesarean section or by the vaginal route 8–12
months postpartum. Of the 184 delivered by ces-
arean, 104 were emergency cesareans and 80 were
elective procedures. They were matched against
100 women who delivered vaginally. Issues related
to bowel habits, urgency, incontinence of flatus and
feces, soiling and pad use before and after the
delivery were quantified. Anal incontinence was
reported in 5% of mothers who delivered by ces-
arean and 8% of mothers who delivered by the
vaginal route. The symptoms were severe in two
women delivered by cesarean and one who had
vaginal delivery. Nearly 25% of women, who had
second degree tears had anal incontinence com-
pared with one out of 40 in those who had an intact
perineum. This suggests that the pelvic nerves
innervating the anal sphincters get damaged due to
pressure during the latter part of pregnancy or early
labor and give rise to anal incontinence in many
cases, whilst a few cases may be due to the actual
physical damage of the sphincters. Perhaps those
who have sphincter damage are more likely to get
severe incontinence, but this needs to be estab-
lished. This study and others similar to this are
useful in counseling women who request cesarean
section for non-medical reasons or for the fear of
anal incontinence.
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